weight loss
about weight loss
Weight Loss Injections & Clinic in Dubai
GLP-1 Therapy at Dr. Namshi’s Aesthetic Medicine & Dentistry
The science of weight management has been transformed in the past decade. A growing body of research has established conclusively that obesity and significant overweight are not failures of willpower they are complex conditions influenced by genetics, hormonal regulation, gut physiology, sleep, stress, and metabolic variability that differ meaningfully between individuals.
For patients who have struggled to achieve or maintain a healthy weight despite sustained dietary effort, this understanding is validating and it explains why medically supervised weight loss treatment, including GLP-1 receptor agonist therapy, has produced outcomes that nothing previously available in non-surgical medicine could match. At Dr. Namshi’s Aesthetic Medicine & Dentistry in Dubai, our weight loss programme combines the most advanced pharmacological options with personalised clinical oversight and practical lifestyle support to deliver a genuine, sustainable outcome.
Make Appointment
The Biology of Weight Regulation
Weight is regulated by a sophisticated interplay of hormonal signals between the gut, the brain’s hypothalamus, and the body’s metabolic tissues. Key appetite-regulating hormones include ghrelin (the hunger hormone, secreted by the stomach), leptin (the satiety signal from fat tissue), insulin, and the incretins a family of gut-derived hormones including GLP-1 that are released in response to food intake and modulate insulin secretion, gastric emptying rate, and appetite. In many patients with obesity, this regulatory system becomes progressively dysregulated leptin resistance develops, ghrelin suppression after eating is impaired, and the normal post-meal satiety response is blunted. The result is a biological drive toward increased food intake and fat storage that operates independently of conscious dietary effort.
Medical weight loss treatments work directly within these hormonal systems resetting the regulatory signals rather than simply imposing caloric restriction from the outside. This is why medically supervised programmes consistently outperform dietary intervention alone, and why GLP-1 therapy in particular has produced the most significant pharmacological weight loss outcomes in clinical history.
GLP-1 Receptor Agonist Therapy: How It Works
The most widely prescribed GLP-1 receptor agonists for weight management include semaglutide known under the brand names Ozempic (diabetes management dose) and Wegovy (higher weight management dose) and liraglutide (Saxenda). Landmark clinical trials have demonstrated that patients treated with semaglutide at the weight management dose achieve average body weight reductions of 10–17% over 68 weeks far exceeding what any previous non-surgical pharmacotherapy could produce. These results are accompanied by meaningful improvements in cardiovascular risk markers, blood pressure, lipid profiles, and glycaemic control making GLP-1 therapy a clinically significant intervention that addresses both the weight and its associated health consequences simultaneously.
Our Medical Weight Management Programme
Comprehensive Initial Assessment
Every patient entering the Dr. Namshi’s Aesthetic Medicine & Dentistry weight loss programme begins with a thorough medical assessment: clinical examination, BMI and body composition measurement, metabolic blood panel (HbA1c, lipid profile, liver and thyroid function), blood pressure evaluation, current medication review, and detailed medical history. This assessment identifies any contraindications to GLP-1 therapy, establishes baseline metabolic health markers, and ensures the treatment plan is appropriate for each individual’s clinical profile.
Personalised Treatment Plan
Based on the assessment findings, a personalised treatment plan is built covering medication selection and dosing schedule, a dietary framework aligned with the metabolic effects of the chosen pharmacotherapy, physical activity recommendations calibrated to current fitness level and lifestyle, and sleep and stress optimisation strategies that support hormonal regulation. GLP-1 therapy is initiated at a low starting dose and titrated upward according to a structured protocol designed to minimise the gastrointestinal side effects (principally nausea) that commonly occur during the early weeks of treatment.
Regular Clinical Monitoring
Monthly appointments in the first three months, transitioning to the appropriate review frequency thereafter, allow our team to monitor weight progress, review side effects, adjust dosing, and provide ongoing nutritional and motivational support. This monitoring structure is not optional it is what distinguishes effective medical weight management from self-administered weight loss attempts that lack the clinical feedback loop essential for safe and sustained progress.
Who Is Eligible for Medical Weight Loss Treatment?
Medical weight loss at Dr. Namshi’s Aesthetic Medicine & Dentistry is appropriate for adults meeting the following criteria:
- BMI of 30 or above, regardless of associated health conditions
- BMI of 27 or above in the presence of at least one weight-related comorbidity: type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea
- Inability to achieve sustained weight loss through dietary and lifestyle intervention alone
- Willingness to engage with a medically supervised programme including regular follow-up appointments
GLP-1 receptor agonist therapy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN type 2, and requires careful management in patients with a history of pancreatitis or specific gastrointestinal conditions. Our assessment process identifies all contraindications before any prescription is made.
Complementary Body Contouring
Medical weight loss addresses the systemic challenge of overweight reducing total body fat mass and improving metabolic health throughout the body. It cannot selectively target specific areas of stubborn localised fat that may persist even after significant overall weight reduction. Many patients who achieve meaningful weight loss through GLP-1 therapy choose to complement their results with non-invasive body contouring treatments at an appropriate stage addressing residual fat deposits in the abdomen, flanks, or thighs through cavitation, cryolipolysis, or RF body contouring. Lymphatic drainage therapy supports the metabolic processes associated with fat mobilisation and significantly improves the comfort and speed of results from body slimming treatments.
Weight Loss Programme Cost in Dubai
The cost of our weight management programme is presented in full at your initial consultation and reflects the medical assessment, monitoring appointments, and medication costs involved. There are no hidden fees. We provide complete pricing transparency from the outset because a clear understanding of the investment is part of an honest clinical relationship.
Frequently Asked Questions
GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) mimic gut hormones to reduce appetite and slow gastric emptyin
Adults with a BMI of 30+, or BMI 27+ with a weight-related condition like diabetes or hypertension.
Yes when medically supervised; the main side effects are nausea during dose titration, which resolves with the structured protocol.
Yes — monthly monitoring appointments are essential for dose adjustment, safety checks, and sustained progress.
